The main indication of transjugular intrahepatic portosystemic shunt (TIPS) is the treatment of variceal bleeding and refractory ascites in cirrhotic patients. In the presence of portal vein thrombosis in patients with cirrhosis, the risk of variceal bleeding increases and portal vein access during the procedure can be difficult. Various approaches including transhepatic, trans-splenic approach...

One hundred and twenty two patients who presented with variceal bleeding as a result of extrahepatic portal vein obstruction (EHPO) were entered into the sclerotherapy programme with a mean follow up of 23.69 months (range four to 60 months). Eighteen (14.7%) patients were lost to follow up, three (2.4%) patients underwent surgery, and six (4.9%) patients died. Variceal obliteration was achieve...

Endoscopic variceal ligation (EVL) can be performed as an optional therapy for gastric variceal bleeding if endoscopic sclerotherapy (ES) is not readily available or if practitioners lack experience. EVL using an endoscopic pneumo-activated ligating device was performed on a 53-year-old male patient with liver cirrhosis who presented with hematemesis. Follow-up esophagogastroduodenoscopy (EGD) ...

The creation of transjugular intrahepatic portosystemic shunt (TIPS) is a widely performed technique to relieve portal hypertension, and to manage recurrent variceal bleeding and refractory ascites in patients where medical and/or endoscopic treatments have failed. However, portosystemic shunt creation can be challenging in the presence of chronic portal vein occlusion. In this case report, we ...

Variceal bleeding is one of the most serious complications of portal hypertension. The driving force for the development of varices is an increase in portal pressure. As portal hypertension progresses, varices dilate until they finally rupture and bleed. This sequence of events might be prevented by achieving a sufficient decrease in portal pressure or by acting locally at the varices with endo...

background to compare the efficacy of a 48 hour infusion of octerotide with a five-day infusion to prevent rebleeding and mortality at one week and one month in patients who present with acute esophageal variceal bleeding. materials and methods patients who presented to emam hospital of ahwaz jundishapur university of medical sciences that were diagnosed with acute variceal bleeding were commen...

Variceal bleeding is one of the grave complications of cirrhosis and is associated with significant morbidity and mortality. Approximately 30 to 70% patients with cirrhosis would have gastroesophageal varices with approximately one-third developing variceal bleed.1 Treatment options include control of bleeding locallywith endoscopic techniques along with vasoactive drugs and antibiotics and red...

ambulance to our institution because of hematemesis. Her medical history included alcoholic cirrhosis with no regular medical follow-upor treatment. Emergency esophagogastroduodenoscopy (EGD) identified a “bleeding jet” from isolated gastric varices in the fundus (●" Fig. 1). Hemostasis was immediately achieved with a hemoclip (●" Fig. 2), and finally a total of eight hemoclips were applied to ...

Squamous cell carcinomas of esophagus are responsible for more than 80% of esophageal malignancies in Turkey. Idiopathic portal hypertension is a rare underlying cause of esophageal variceal bleeding. In such cases, detection of concomitant esophageal squamous cell cancer is also a rare occurrence. We report an unusual case of bleeding esophageal varices secondary to idiopathic portal hypertens...

Background and Aim: Portal hypertension in pregnancy is an infrequent situation but when seen together present as a complicated clinical situation. The physiological changes adaptation to fetal needs worsen the portal resulting potential life-threatening variceal bleed. Variceal hemorrage associated with increased risk of maternal mortality. Glue has become increasingly utilised acute managemen...